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Abstract
 
Introduction
Most  studies  that  describe  hospice  use  among  cancer 
patients  use  the  Surveillance,  Epidemiology,  and  End 
Results (SEER)-Medicare database, which has known lim-
itations. We used vital records data to describe patterns of 
hospice use among cancer decedents in Alabama.
 
Methods
To ascertain hospice use, we linked death certificates 
from 2002 through 2005 for people who died from cancer 
to  listings  of  deaths  reported  by  hospices.  To  evaluate 
accessibility of care, we calculated straight-line distances 
between decedent residence at death and the hospice pro-
viding care. We used these distances to estimate the reach 
of each hospice and identify the number of hospice nonus-
ers residing in these areas.
 
Results
During the study period, 52.0% of cancer decedents in 
Alabama received hospice care from 165 hospices. Nearly 
two-thirds of Alabama counties contain at least 1 hospice. 
Whites (53.6%) used hospice at a significantly higher rate 
than blacks (47.0%), but the rate of use was similar for 
women  (53.2%)  and  men  (51.0%).  For  people  who  were 
eligible  for  Medicare,  53.0%  received  hospice  care.  The 
median  distance  between  decedent’s  residence  and  the 
hospice providing care was 9.8 miles. This distance was 
slightly shorter for blacks than whites and roughly equal 
by sex.
 
Conclusion
Alabamians use hospice at lower rates than observed 
elsewhere. Barriers to hospice care in Alabama must be 
identified and addressed.
Introduction
 
The 1982 Medicare hospice benefit allowed beneficiaries 
with  a  life  expectancy  of  6  months  or  less  to  exchange 
curative  care  for  comprehensive  hospice  care  (1).  Since 
then, the number of hospices providing care in the United 
States  increased  from  approximately  1,500  in  1985  to 
4,500 in 2006 (2). In 2006, an estimated 36% of all deaths 
in the United States occurred while the patient was under 
the care of a hospice program (3). Despite the widespread 
adoption  of  hospice  services,  an  Institute  of  Medicine 
report concluded that a substantial number of people con-
tinue to experience needless distress at the end of life that 
might be alleviated by hospice care (4).
 
Historically, cancer patients have made up the largest 
proportion of hospice users, although this percentage has 
been declining (2). Since nearly half of all hospice users are 
cancer patients, hospice use among cancer patients has 
been described by using the Surveillance, Epidemiology, 
and  End  Results  (SEER)-Medicare  database  (5-11).  In 
2007,  65%  of  Medicare  recipients  dying  from  cancer 
received hospice care (12), but few studies describe hospice 
use  among  cancer  patients  outside  the  SEER-Medicare 
population. A 2006 study used health maintenance organi-
zation (HMO) administrative data to describe hospice use 
among cancer patients (13). Although that investigation 
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provided estimates for all cancer deaths (people aged 21 
years and older), generalizability may have been limited 
because it was conducted in an HMO — a population that 
uses hospice services at substantially higher rates than 
does the general population (14).
 
To overcome deficiencies in previous studies, we used 
death  certificate  data  and  other  administrative  reports 
from the Alabama Department of Public Health (ADPH) 
Center for Health Statistics to describe and compare pat-
terns of hospice use among cancer decedents of all ages in 
Alabama. Recognizing that some people are unaware of 
the services and support through end-of-life care and are 
unprepared for their own death or the death of a loved one, 
and that some health care professionals are not prepared 
to talk with family and patients about these issues, we 
developed the “End-of-Life Care” section of the Alabama 
Comprehensive Cancer Control Coalition (ACCCC) 2006-
2010 Plan (15) to promote public awareness and educate 
health care professionals about these issues. By establish-
ing  a  baseline  metric  for  hospice  use,  we  can  evaluate 
the end-of-life care objectives outlined in the plan. To our 
knowledge, this is the first investigation to ascertain hos-
pice use among cancer patients primarily on the basis of 
death certificate information.
Methods
Hospice use
 
We  used  death  certificate  and  other  administrative 
records to identify hospice use before death. We obtained 
death certificates from January 1, 2002, through December 
31,  2005,  for  Alabama  residents  who  died  from  cancer 
(International  Statistical  Classification  of  Diseases  and 
Related Health Problems, 10th Revision [ICD-10] codes 
C00-C97)  in  Alabama  (N  =  37,864)  from  the  Alabama 
Center  for  Health  Statistics.  By  law,  the  physician  in 
charge of care for the patient is responsible for providing 
the cause of death on the death certificate; if the person 
was not under the care of a physician, the coroner or medi-
cal examiner determines the cause of death (16).
 
To ascertain hospice use for each decedent, we manually 
matched death certificates to the hospice that adminis-
tered care by using listings of deaths reported by hospices. 
To verify that a death certificate is filed for each deceased 
person  in  the  state,  Alabama  law  (17)  requires  every 
health  care  institution,  including  hospices,  to  provide  a 
monthly listing of all deaths that occur under their care to 
the state registrar of vital records. We merged data from 
these monthly hospice-specific death reports to the corre-
sponding death certificates, creating a new death file that 
included  a  hospice  identifier.  Since  all  hospice-reported 
deaths were matched to a death certificate, we could exam-
ine demographic and cause of death information by the 
specific hospice that provided care at the time of death and 
compare that information with information for decedents 
who did not receive hospice care.
Geocoding
 
Alabama hospice facilities are primarily offices where 
business is conducted; 2 residential hospices with 10 beds 
each were included in the data. To visually assess use of 
hospice care, we geocoded all decedent and hospice facil-
ity addresses to the street level by using ArcView version 
9.2  (Environmental  Systems  Research  Institute,  Inc, 
Redlands, California) and a Web-based geocoding applica-
tion  at  www.batchgeocode.com.  We  geocoded  a  random 
sample  of  hospice  addresses,  using  both  ArcView  and 
batchgeocode.com, to evaluate the validity of results using 
the online geocoding tool. We calculated distances between 
each method’s geocoded location by using the Great Circle 
Method (18). This metric determines the shortest straight-
line distance between 2 points (geocoded x and y coordi-
nate values) on the earth’s surface, accounting for the cur-
vature of the earth. Addresses geocoded by the 2 methods 
differed in geographic position by an average of 0.29 miles 
(n = 100; 95% confidence interval, 0.08-0.51 miles; P = .01). 
Although the 2 methods produced significantly different 
results in terms of geocoded location, the observed differ-
ence was not considered to meaningfully affect results in 
this investigation. Previous findings in the literature have 
indicated that the positional accuracy of geocoded locations 
obtained with ArcView software was equivalent to those 
provided by commercial firms (19). Given the comparable 
level of accuracy with ArcView, we determined that the 
online tool at www.batchgeocode.com was a well-founded 
geocoding method for this investigation.
 
We  geocoded  decedent  addresses  by  using  a  stepwise 
process.  We  first  geocoded  addresses  with  ArcView’s 
StreetMapUSA  reference  data  (2000  Topologically 
Integrated Geographic Encoding and Referencing system 
[TIGER] street data). We then geocoded addresses that 
were not matched in this first stage by using the online VOLUME 6: NO. 4
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tool at www.batchgeocode.com. We geocoded records not 
matched by either method to their zip code centroid (center 
point of the zip codes). Most decedents (31,352 of 37,864, 
83%) were geocoded in ArcView, and 17% were geocoded 
(6,437  of  37,864)  with  the  Web-based  application.  Less 
than 1% of cancer deaths (73 of 37,864) were geocoded to 
their zip code of residence centroid. We were unable to 
geocode 2 death certificates that were completely missing 
address information.
 
We created maps that depicted county-level hospice use 
rates (by quartiles) in ArcView. We calculated distances 
between residence at death and the hospice that provided 
care by using the Great Circle Method (18). We also used 
this distance to estimate the reach of each hospice and 
capture the number of hospice nonusers residing in these 
areas.
Decedent characteristics
 
We used the following fields from Alabama death cer-
tificates: year of death (2002, 2003, 2004, or 2005), race 
(white  or  black,  which  includes  all  nonwhite  races,  of 
which  99%  are  black),  age  at  death  (≤34,  35-44,  45-54, 
55-64, 65-74, 75-84, or ≥85 years), marital status (never 
married, married, widowed, or divorced), ICD-10 underly-
ing cause of cancer death (lung, C33-34; colorectal, C18-21; 
female breast, C50; prostate, C61; pancreas, C25; or all 
other cancers combined), and sex.
Statistical analyses
 
We calculated crude rates of hospice use by each char-
acteristic.  Categorical  variables  were  assessed  by  using 
χ2 tests, and continuous measures were examined with t 
tests. To compare our results with findings from SEER-
Medicare–based  investigations,  we  also  calculated  rates 
of hospice use among decedents aged 65 years or older at 
death. This research received approval from the University 
of Alabama at Birmingham institutional review board.
Results
 
From  2002  through  2005,  slightly  more  than  half 
(52.0%) of Alabamians who died from cancer were receiv-
ing hospice care at the time of death (Table). In this period, 
165  hospice  entities  provided  care  to  these  people,  and 
51 of Alabama’s 67 counties (76%) contained at least 1 
hospice (Figure 1). Hospice use varied widely by county of 
residence, from a low of 35.9% in Butler County (75 of 209) 
to a high of 70.8% (461 of 651) in Lee County. Counties in 
south-central Alabama were in the lowest quartile of hos-
pice use (35.9%-47.5%) (Figure 2). Several of these coun-
ties did not contain a hospice. 
 
Whites (53.6%) used hospice care at a significantly high-
er rate than did blacks (47.0%) (χ2 = 116.6, df = 1, P < .01), 
and the proportion of use for women (53.2%) was margin-
ally larger than that for men (51.0%) (χ2 = 18.0, df = 1, P 
< .01). Slightly larger proportions of white women (54.7%) 
Figure 1. Location of hospices and cancer deaths under the care of a hos-
pice, Alabama, 2002-2005.VOLUME 6: NO. 4
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than white men (52.6%) (χ2 = 13.7, df = 1, P < .01) and of 
black women (48.2%) than black men (46.0%) (χ2 = 4.3, df 
= 1, P = .04) received hospice care. As expected, hospice 
usage rates significantly increased with age at death (P for 
trend <.01). White hospice users were comparable in age 
at death with black users (70.7 vs 68.9 years) (t = 7.14, df 
= 5,918, P < .01); female and male users were also similar 
in age at death (70.9 vs 69.7 years) (t = 6.25, df = 19,700, 
P < .01). Age-specific hospice use varied by race and sex 
(Figure 3). White women, followed by white men, had the 
highest rates of use across most age categories. Black men 
had the lowest rates of use for most age groups.
  
Slightly less than 70% of users were aged 65 years or 
older at death, and more black than white hospice users 
were  younger  than  65  at  death  (36.5%  vs  29.5%).  To 
compare these figures with results derived from SEER-
Medicare data, the rate of hospice use was calculated for 
those aged 65 years or older at death. Of Medicare-eligible 
cancer decedents in Alabama, 53.0% received hospice care 
from 2002 through 2005.
 
Overall, the median distance between decedent’s resi-
dence and hospice location was 9.8 miles. This distance 
was shorter for blacks than whites (6.6 vs 10.6 miles) and 
roughly equal by sex. Among decedents who did not receive 
hospice care, 60% lived within 10 miles of a hospice, the 
median distance among users (Figure 4); 77% of nonusers 
lived within a 20-mile radius. Results did not vary by race 
or sex. Among hospice nonusers aged 65 or older at death, 
64.2% lived within 10 miles and 77.2% were within 20 
miles of a hospice.
 
Discussion
 
In Alabama from 2002 through 2005, hospice use at the 
time of death for cancer patients was 52.0%, which is well 
below figures reported for other locations. From 1996 to 
2001, 65.4% of HMO enrollees in northern California who 
died  from  cancers  of  the  lung,  colon-rectum,  breast,  or 
prostate received hospice care (13). In contrast, only 52% 
Figure 2. Hospice use among cancer decedents by county of death, 
Alabama, 2002-2005.
Figure 3. Hospice use among cancer decedents, by age at death, race, and 
sex, Alabama, 2002-2005. VOLUME 6: NO. 4
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to 55% of comparable cancer deaths in Alabama (2002-
2005) were among people who were under hospice care 
at  death.  This  discrepancy  may  be  partially  explained 
by the fact that HMO enrollees have significantly higher 
rates of hospice use (14). However, given the difference in 
time between these studies, one would expect the differ-
ence in rates to be smaller, since hospice use, in general, 
has increased over time. This difference may reflect lower 
levels of hospice use in Alabama than in other parts of the 
United States.
 Although most publications describing patterns of hos-
pice use among cancer patients have relied on the SEER-
Medicare database (5-11), this study was not limited by 
age or payer source. Slightly more than 30% of hospice 
users who died of cancer in Alabama were younger than 
age 65 at death, although this figure increased to 36.5% 
among blacks. Given these findings, investigations derived 
from  the  SEER-Medicare  database  may  exclude  a  sub-
stantial portion of younger hospice users.
 
To  compare  results  from  this  study  with  SEER-
Medicare–based investigations, rates of use among those 
aged 65 years or older at death were calculated separately. 
During the 4-year study period, 53.0% of Medicare-eligible 
cancer decedents in Alabama received hospice care. A pre-
vious study reported that 65% of Medicare recipients who 
died from cancer in 2002 received hospice services (12). 
By  comparison,  hospice  usage  among  cancer  decedents 
aged 65 years or older in Alabama in 2002 was 52.2%. The 
discrepancy in estimates likely results from a combination 
of factors. Although the Medicare-eligible population was 
restricted to those aged 65 years or older, approximately 
3%  of  eligible  Americans  are  not  enrolled  in  Medicare 
(20).  Additionally,  analyses  using  SEER-Medicare  data 
can  identify  live  hospice  discharges  (12),  whereas  our 
method prevented us from doing so. Live hospice discharge 
estimates range from 6% of all hospice users to 15.5% of 
Medicare recipients (21,22). Some investigations have also 
shown that people with a cancer diagnosis are significant-
ly less likely to be discharged alive compared with those 
with diagnoses other than cancer (21), but other studies 
have found no such association (22).
 
Hospices in Alabama are regulated by the State Board 
of Health through the Division of Health Provider Services 
in  the  ADPH,  with  no  certificate  of  need  requirement. 
Currently, there is a moratorium on licensing new hospic-
es. In accordance with Act 2006-617 of the 2006 Alabama 
Legislature (23), Alabama can issue a new hospice license 
only if an applicant has met specific requirements and if 
the application was filed by July 7, 2007, or the ADPH has 
inspected all licensed hospices in the preceding 12 months. 
Therefore, applications for new hospice licenses will not be 
accepted until the ADPH inspection process is current (24). 
This moratorium on new hospice licensing raised concerns 
for the Survivorship Workgroup associated with ACCCC. 
However, results of the analysis of catchment areas for 
each  hospice  found  that  60%  of  hospice  nonusers  lived 
within 10 miles of a facility (the median distance among 
Figure 4. Location of hospices and cancer deaths among people who did not 
receive hospice care, Alabama, 2002-2005. Circles show the 10-mile radius 
around each hospice, which was the median distance between hospice and 
residence of hospice users; 60% of hospice nonusers would have been cap-
tured in this radius.VOLUME 6: NO. 4
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users), and 77% lived within 20 miles, which implies that 
distance is not a barrier to hospice care for most hospice 
nonusers in Alabama.
 
Strengths of this investigation primarily relate to the 
data  sources  used  to  ascertain  hospice  care.  First,  this 
study  analyzed  nearly  38,000  cancer  deaths.  The  novel 
technique  to  determine  hospice  use  is  also  an  asset 
because this study was not restricted by age or payment 
method, since it was population-based. This method for 
determining  hospice  use  also  has  benefits  over  studies 
that use death certificates alone. Many states are chang-
ing  their  death  certificates  to  follow  recommendations 
(25)  presented  for  the  2003  US  Standard  Certificate  of 
Death (26) that called for adding a box under “place of 
death”  for  “hospice  facility”  to  distinguish  those  deaths 
from deaths that occurred in a hospital, nursing home or 
long-term care facility, decedent’s home, or other location. 
Instructions for completing this new category state that 
“hospice facility refers to a licensed institution providing 
hospice  care  (eg,  palliative  and  supportive  care  for  the 
dying), not to hospice care that might be provided in a 
number of different settings, including a patient’s home” 
(27). Thus, states that use this new version of the question 
would be able to examine characteristics of people who die 
in a hospice facility; however, they still would not be able 
to study deaths among all people under hospice care. By 
2008, approximately half of the states had adopted this 
update (26).
 
This study has several limitations. Because this study 
measured  hospice  use  at  death,  people  who  were  dis-
charged alive from a hospice facility were potentially mis-
classified as nonusers. Such misclassifications could result 
in underestimates of the true usage rates. These results 
may not be generalizable outside of Alabama, although 
rates of use in Alabama displayed many of the same pat-
terns observed nationwide, albeit at a lower rate of use. 
Finally, positional accuracy of geocoding is lower for rural 
addresses (19), so distances calculated between residences 
and hospices in rural areas are likely to have a higher 
degree of error than in nonrural areas.
 
Our study provides valuable baseline data for the “End-
of-Life  Care”  section  in  the  ACCCC  plan  and  reveals 
racial, geographic, and other disparities in hospice care 
use in Alabama. To increase awareness of hospice care, 
the ACCCC has taken steps to disseminate these findings. 
Using maps to visualize the varying patterns of use helps 
the ACCCC concentrate educational messages about hos-
pice services in the areas of most need. In conjunction with 
the study results, the Alabama Hospice Organization has 
garnered wide support for a certificate of need process to 
replace the moratorium on new hospices. That hospice use 
in Alabama is somewhat lower than that observed nation-
ally is a concern of the ACCCC. It recommends conducting 
additional studies to try to determine barriers that might 
prevent hospice use and determine whether family mem-
bers  have  the  appropriate  education  about  the  benefits 
that hospice care can provide to support the family as well 
as the patient. Such investigations are under way.
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Table
Table. Cancer Deaths and Hospice Use, by Selected Characteristics, Alabama, 2002-2005 
Characteristic No. of Deaths % Hospice Use (95% Confidence Interval)a
Total ,64 52.0 (51.5-52.5)
Year
2002 9,61 52.2 (51.2-5.2)
200 9,42 5.0 (52.0-54.0)
2004 9,44 52.5 (51.5-5.5)
2005 9,54 50.5 (49.5-51.5)
Race
White 29,10 5.6 (5.0-54.1)
Blackb ,5 4.0 (45.9-4.0)
Sex
Male 20,501 51.0 (50.-51.)
Female 1,6 5.2 (52.5-54.0)
Age, y
≤34 41 9. (5.1-44.)
5-44 1,06 4.5 (45.5-51.5)
45-54 ,590 49.5 (4.9-51.1)
55-64 ,10 51.2 (50.0-52.)
65-4 10,20 51.9 (50.9-52.)
5-4 10,59 5. (52.9-54.)
≥85 4,2 5.6 (52.-55.1)
Cancer site
Lung 11, 52.5 (51.6-5.4)
Colorectal ,40 5.2 (51.6-54.9)
Female breast 2,665 52.5 (50.6-54.4)
Prostate 2,12 54. (52.6-56.)
Pancreas 1,92 59. (5.1-61.5)
Other 15,6 50.1 (49.-50.9)
 
a Hospice reported death. 
b Black race includes all nonwhite races, of which 99% are black.